Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model.
about
Brivaracetam add-on therapy for epilepsyProfile of brivaracetam and its potential in the treatment of epilepsyBrivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence baseThe pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men[Brivaracetam for add-on treatment in focal epilepsy].Brivaracetam differentially affects voltage-gated sodium currents without impairing sustained repetitive firing in neuronsKv7 potassium channel activation with ICA-105665 reduces photoparoxysmal EEG responses in patients with epilepsy.Extended-release formulations of antiepileptic drugs: rationale and comparative value.Effects of marketed antiepileptic drugs and placebo in the human photosensitivity screening protocol.Emerging drugs for partial onset seizures.Pharmacotherapy of epilepsy: newly approved and developmental agents.Brivaracetam for the treatment of epilepsy in adults.Non-invasive EEG evaluation in epilepsy diagnosis.The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy.Update on pharmacological treatment of Progressive Myoclonus Epilepsies.Evaluation of brivaracetam: a new drug to treat epilepsy.Brivaracetam for the treatment of epilepsy.Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.Update on pharmacotherapy of myoclonic seizures.Effect of Rifampin on the Disposition of Brivaracetam in Human Subjects: Further Insights into Brivaracetam Hydrolysis.Brivaracetam disposition in mild to severe hepatic impairment.Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial.Dose-dependent suppression of human photoparoxysmal response with the competitive AMPA/kainate receptor antagonist BGG492: Clear PK/PD relationship.A review of the pharmacology and clinical efficacy of brivaracetam.Antiepileptic drugs in development pipeline: A recent update.
P2860
Q24188269-B02BAE07-574F-44C7-BEEC-0C19E1D0E6DCQ26776317-90DDCD18-C5BD-4E55-ACE5-39B8E92064BFQ28076065-B71AA68B-B6F2-483B-A04F-0CDD030BC268Q28272717-A581B013-4DF0-4EE7-91AF-EA96E81F15C8Q30390285-B2EEB617-8589-42AF-8081-8F5816503744Q30627739-AC02DF8D-C17B-41E0-A2FA-F94AA61CA51AQ37337679-4E31716B-9EAE-4270-A6C7-F4CEF2858DC0Q37423598-C7853CBF-1C3C-4821-AEF1-C2BFF044E175Q37717412-900C7F70-7C1E-409C-8E1A-D159CC355F0FQ37754477-4EDCB3EF-2E27-4A0B-85A9-394025864B8AQ37831297-2EFB92E0-B0C4-4F6D-A202-521D3925CB3FQ38195636-618DFF0C-BC98-43F0-9558-208A1DBCD81EQ38380950-2EBD1361-ED90-4B69-AF05-CF2FB8062F16Q38614499-7323A4CF-FA39-4E08-9CDB-A5405D067641Q38629165-ECEF0040-B233-458E-924C-621F267A2DFEQ38652806-7FD55A59-7863-4E79-A4CB-AF9CFF6CF041Q38694479-ABCEFFFE-F55E-424F-BF74-54248B7368F0Q38739649-A476992F-C3C2-49D0-8A8B-F11CF442E250Q39032456-40B24A92-B9DA-4341-88C3-0906721EB963Q39899497-4A334A13-7B2C-469F-9698-30C3FB4CC35DQ44231616-FCAD7366-E59F-4D70-AD3C-DDA62FE4DB5EQ44773924-D3F0A0E0-4B9B-4BA8-B17D-F7528968F164Q48188407-71362C13-E609-48A7-A8D0-877B841E7B4AQ49700507-ED5CBE21-F867-4DB8-A998-FECAC31353FBQ49882750-DFE91FBD-43E2-4954-B389-478DB8628A68
P2860
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model.
@ast
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model.
@en
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model.
@nl
type
label
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model.
@ast
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model.
@en
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model.
@nl
prefLabel
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model.
@ast
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model.
@en
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model.
@nl
P2093
P1433
P1476
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model.
@en
P2093
B J Steinhoff
D G A Kasteleijn-Nolst Trenité
E Pigeolet
P304
P356
10.1212/01.WNL.0000271385.85302.55
P407
P577
2007-09-01T00:00:00Z